Records containing: Lupus Erythematosus, Systemic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-11-06An Open-Label Safety and Efficacy Study of an Anti-CD20 Antibody (Rituximab, Rituxan®) for Anti-B Cell Therapy in the Treatment of Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2017-10-26A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2017-10-09A Phase Ib Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biological Effect of MSC2364447C in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2017-08-04The Impact of Illness Perceptions and Their Determinants on Health Related Outcomes in Patients With Systemic Lupus Erythematosus and Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2017-07-24The Use of Riboflavin/Ultraviolet A Cross-linked Human Donor Corneas as Carriers for the Boston Keratoprosthesis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-06-27GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2017-02-28Association Between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2017-02-24Association Between the Presence of Autoantibodies Targeting Ficolin-2 and Active Nephritis in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2017-02-08European Society of Cutaneous Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2017-01-30ClinicalTrials.gov study NCT01838694
-
CLINICAL_TRIALS study record update · 2017-01-23"Color Doppler Ultrasound Comparison of Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud: A Randomized, Double-blind, Placebo-controlled Pilot Study"
-
CLINICAL_TRIALS study record update · 2017-01-11Treatment of Systemic Lupus Erythematosus With CTLA4-IgG4m Plus Cyclophosphamide: A Phase I/IIA Study
-
CLINICAL_TRIALS study record update · 2016-12-16Longitudinal Study of Skin And Systemic Biomarkers In Subjects With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-10-04Comparison of the Clinical Examination and the Joint Ultrasonography in the Evaluation of Disease Activity in Systemic Lupus Patients
-
CLINICAL_TRIALS study record update · 2016-08-23The Effect of Green Tea Extract on Some Inflammatory Biomarkers(IL 6, IL1β,TNF α,CRP), Serum Total Antioxidant Capacity(TAC), MDA and Disease Activity in Patients With Systemic Lupus Erythematous
-
CLINICAL_TRIALS study record update · 2016-08-09A Phase 2A , Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Study to Evaluate the Safety and Tolerability of Multiple Subcutaneous Doses of MEDI-545, A Fully Human Anti-Interferon-Alpha Monoclonal Antibody, In Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2016-06-08A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
-
CLINICAL_TRIALS study record update · 2016-03-14A Randomised, Double-blind, Placebo Controlled, Multicentre Prospective Dose-finding Phase II/III Study With Atacicept Given Subcutaneously to Subjects Having Recently Experienced a Flare of Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2016-02-18ClinicalTrials.gov study NCT00005436
-
CLINICAL_TRIALS study record update · 2015-08-03Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
-
CLINICAL_TRIALS study record update · 2015-07-16A Multicenter, Investigator- and Subject-Blind, Randomized, Placebo-Controlled, Parallel-Group, Repeat-Dose Study to Evaluate the Effect of CDP7657 in Subjects With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2014-10-09A Randomized, Double-Blind, Controlled, Phase II Multicenter Trial of CTLA4Ig (Abatacept) Plus Cyclophosphamide vs Cyclophosphamide Alone in the Treatment of Lupus Nephritis
-
CLINICAL_TRIALS study record update · 2014-09-12Cross-Sectional Study in Subjects With Active Cutaneous Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2014-08-26A Phase 1, Double-blind, Randomized, Single Ascending Dose Study of the Safety and Tolerability of MEDI-570 in SLE
-
CLINICAL_TRIALS study record update · 2014-06-10A Pilot Study of Intensified Lymphodepletion Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Systemic Lupus Erythematosus